File ID,File Name,Run Metadata ID,Study Name,PDC Study ID,PDC Study Version,Study ID,Project Name,Data Category,File Type,Access,File Size (in bytes),Md5sum,Downloadable,File Download Link
"0b4b0dc5-df0a-4f18-965c-2156d95ed09a","PTRC_4patient_Plex_02_G_f02.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","826968196","3f4f317bf6985c3026846e42f6a21cae","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f02.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=WknNl6XnUTtwd~kSFe-LF9fXHI35sueWWkQGm4LaSaXHITjdxCgxvrXct5G2utqYSrutCxKIee-wNzFY1RS2MVrRJc-HpkCYBPPuLRYzKUqQFnLubcPZv8hnhRKjH~eoCOnJtPTAJS5fxn2bk4NkpOOgPpXgU56NjO4zoFGAoIHR82sXhxV-Eij98wFw02rIVOMKyiXKFDKpuhdo5AWgTd4PrQx9cVRYKV~XWsEHW4X5ay~gB5n--UEpUEBecad54ugwjuQGfzwh8YDN6TLlMobmXrcnlXGiju2BIhwtEZLgS5DGlP9cSH0aUaKwEBUSHveJovj-6qLrfB7LTvuM1w__"
"0d2fd9a5-0286-4396-a4d6-bc2787e32418","PTRC_4patient_Plex_02_G_f06.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","895805252","94538345a013cc301a53c939cb3bd0d6","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f06.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=g5e9stfERou~IW7qgi47Zdc9rQGXCVNzYit6dW-6tzBs1O8HF4eAI5~hIpdAUAHVH~IjaTcrjj4BgGs4q1SqdXE58-zN~rjksrRKf55RFIUyEPkYYaXrY2CZWUJs0LbjycvX51oHhyoUGGSSVb~QnK4f8muT0lvJmQF-H7O0ZxrxwDZ~DuReVy-mXlKpzKw8elhnJDR~u3Gj4rRfyYIFZ5uw5NutkBRKGk8CuISmpMcl17hhSDQduaXhMWakmHwOTqgXEddh~0SlvfgWtAdOEdbLV3gQKOaUbpFDXCI31gCA5uVkOySPDPwfPxVX0JzZoCc74-fuA40hCSsynVZyCQ__"
"2dfd5457-9913-4abf-a354-1cce31406daf","PTRC_4patient_Plex_01_G_f12.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","822507708","a5eebebd4ad9fbc5530fea793d8a2302","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f12.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=ZMk~EfuQC-xlYUNLamYS7Ga6YCmFtIBP0mK4fy-3kHQQJyEfet-3ypErBWpKW~g5anc1YzrqwGGUd~Y5xVNJsoohZxm7BoHhby5YWNzIGJSrXO9hXArMrf9pXa9OCUD-i2nkCd0GA~5x~47Q5vPHpgP1kQsqVOHyqcOLANmpO4TbTbg-HGSQ8AiPwlAJQTmVBw2P4adweBATDnSbdAaIYNntRJmQPmzdRBl42CTRZzPV9Pp1EfzUm9L4a~eOdnAJTBbYd2APcrT2-EAML~W~7swwwoKdNEkhf08zpN1VpfT~9RxCpRtHiFsV5zWszZQFlM9Kn~HMAnV3pOKy2CwaPg__"
"41b01bc2-8ffe-4d12-91df-cdf905f7686c","PTRC_4patient_Plex_02_G_f04.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","815811608","f9e883ed3ef63df4b716e4e0902f7371","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f04.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=ahIC40TUMWrmIgQQvwoK0CIUwN24JH~Nvqm-cTqtf~2epaIp3Q0mElDPquBrQJGreBrcPKAAl6fM8GvuImeEuuVGWE02yWoKvLMAhuIW~Bj8UqK9KrG1h43eTyCwR722vEFWy6RfXClsc6V1mZcYmXZRXA1dKvr5Oj4o~5d-PF7rSYRUGlGDv40abhxfwOw7ScxMsPxrbZ~b~Hn9qqPxLDXYtICfDlWanXhHDV5ZPP0lD9FhwLEOtmpfinHbDBcn-H4FLtKXcveAWs2Al3P-ctrsDDmjyGe15zM8QEtErn9LPnR9ysZd9hhvkSR89Kn9Fe05MoITSAyEU9sO5tPVoA__"
"43f05f50-445c-41fa-9ec0-7b0d6965e5d3","PTRC_4patient_Plex_01_G_f08.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","808793308","d070c197d18c0f14c2ec51ec80e0feac","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f08.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=ZMCSH7UXZIzt5BNsxdca8h1lxXQINwL2NueEXkswZ1CBmq9UYSnvw7FNi5aYzNKQs8AQuUvFBy~ooJhQ3RKn3QEAJOOyx4K8DeatwwpwIchA1NqV0dvxG-ELczrI05EML5zbdcE0bhTxvDeL5mBiJayGdsD4q7VOWs7qIQ1mJsSYy3igHOGL8C7BXH0KK2GRBWCbgRxm9NoA07ntPMFR7OIogt5b1-7PnTzIt-PPZ4YQLrTc1GFj51n9FSlOkwwGiFfdvS56IebliykSQBBCMZ0yOpwbB-9X-VSxYg8RiFQtZXC2Tqy5SCk1Lq~EZ9k~lgCPQ4VRtRtNw9bLCHJtsQ__"
"4ed1ee52-8da8-4616-970a-920af90d83e5","PTRC_4patient_Plex_01_G_f06.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","813464772","e2bfe8dd1412cbb3feac5f826811bf09","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f06.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=cc1crZzN6iTxxzljoxghBRhL~xB5zUy2EM0eh5Mo41dHGkKq~69-fG3ga96LmgClL9BZc2bT6TQIHjff~TvCJuYIiKciStCIKBRgo5o81k1jQENwcAxy3Tf5X9JZn7Nd2SENk3gfcx8TRBLoLzPJFHGjc0JxeNke-mHAYXeFPLh5CiLvkH3fLes8yH52xbI8KnKsvcFVr7I~yRDP42lDB~xnUEr0RDN8ED6-Oy3-w-lGye8Z28TIrswaXCXZC5Hgs-jPD21aD0i3KgyS6~YFPS18cQmJBhivjS85QTw74ED4-aFVYB-ykrPJ227cQoJWFm~n8dwKpDtrf0yG2NlGjg__"
"5e97bf04-5042-4fed-81c9-0ed052fd1e5e","PTRC_4patient_Plex_02_G_f05.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","812232886","9df728c6995644675bea32f335e9b287","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f05.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=DT-30eDlVHP~CaqFoidjf4toGLXIqtOmBO8nNn9OjW~KFMGNvvH87SUp640DgyViNS2sA5anOyIv9dng3-ijvAslF~32TXDUrhEPwoEHT28SIGLNCkt0WFW8rvg~EKuuOC3ogxfTJnYD6Xy7-Ie5HAtpyT-1fq8fi0wFxt-mrxbivRiVuRqBgGQZm97b5~BmKUgd6C5ml2wFo7CurD1nEMazc6IS0qwpna9p2VrxkfamTHo4EEyPETasizDr178ogPaPXbOi2sYZyx453scUHk~tUX-8ZhoNR~cjmHBTVZAqLYlHPFIMhBEPqPIoxhHp3OqleL4YN3QMgZ5ACyn6XA__"
"631dc238-690b-4450-8b45-a9375f59d0b8","PTRC_4patient_Plex_01_G_f04.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","876512016","b912c27752727a0220d7567355dcbf1e","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f04.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=KXzGY8T4elkgyWJbBj9bv8j0Q799zJYNzYXspS1B3ei6zuAogMXnzBGr8uvsWofq-k4IZ2vxr2ZueLtr7TLyl1RE1dQn4-wCZucLG~wbfK7xF6N5rmV3JL2sl6vILLXdKNu08xxwMelsEeepAiw4dAcqUYSg1vqwPofqTKQ6dWWK8RE0bHI4jQaR5nNwSnwNizh8JWQfxwzFNWpHPr5NGLtOpEaMX7cE8RcRRcaX48l6-xq337Xb6tPpY9Ewz~E8l3KHN7Lv-87-rrruxgL8NHPoZz6IzBUWOQsFeCEqzdsR93xj69AFuLYwMoDDLetzeyi16a3kKpQhEiQacK7C4A__"
"74578fa8-8773-4958-86f2-c9595af3ac06","PTRC_4patient_Plex_01_G_f09.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","817484352","0e7a822128afae77bbb19154eb644050","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f09.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=P6to1AjNXs7bI5aLONe5ro8qcqVpVRHv9EcMRUkshxk71kL2LhMzDXgFMezOdgFmFz6NqZNvI~jzgKN2NU6ynU7Si5XgfZHGDKtE~WBrxKSEWZmUVbF6W2vnLgB7lgBGHRLbqyRrB31ak0gLUOx8kynYXK~EZEm7ha9oGui4X7YAAx0hP5uQ5rDxuYzeCg1u8DmkIMm2xJVbejlbfa7-xF9VtPFS4Y~wvbtElC-NKJx4CGKJ17KpA0qK2VNKElezLsqVivMqSurRfJUpc7ARflLzfcq7oigNKDlbJVpFFOugjwJbMLsDmTePoCYo~rym2H91xL2tpX99Xg3YXLFdLg__"
"75567aee-db39-4b27-8298-3f813d8b98b5","PTRC_4patient_Plex_01_G_f01.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","877973540","c128838299265a9ee92009ad1589a11d","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f01.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=Ch41x3Q-c7UxcLz64DhA9yCn1kbrMCyfNDRtOEobRDM~DJZX1xJS9d2nBe0nZax-NJ0VCGRQ0eREs1d-CnDDsEg4aGpYzIIljyQVndHEptGnNVF51PxdXO3r0jVmzYYOP8jbQ7MRI2FeDAaeiJ8hsvBG6kHgyKgUJRunx-UcjoQh2FJJV85hFBj8HFy3irGxQ0kZtEhGP7Y~Nsaif9NBuD~0rIEEbm08DlWRBQZ6jSTHMk-WbwUf8QuaLqykrs6vEOCJGkfPrAgWpvIFL0bGobrc6diFxs9lAHmOT-GAqZ8gEEmV2BuFK4002s5wRtnYhi9~PsOqB3k6M5przS5eCA__"
"8ae0e819-d150-460e-8b38-0ecf82f8d7ea","PTRC_4patient_Plex_01_G_f11.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","831274940","060be65d670c5240bf533d6aea1f494f","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f11.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=COpy6SFfsfDHNuqk3v1WSxgPXpHNMiAC-Kszzh77AuhgKgmREpEsuXdZ9MFBmu0jaD1cTM4gWAF11eFxOo49dpUCb7hZgClpvZXddo01o2Ui5bZyRKPqptv1mthwG4adNpQro7gzh85l6J5TX1Gndis22ikYx0rYBldIbURrTptDqtmBKrtBt0StAG6OdefUrmLPuBlEYb5po3Q0qxmiAy4TckFM2W0BJaseaUAasLg9esOwxqgmToYIIqjuJNo8v26BdZRrJ1HYnayTOdpf7JGNUDTB5lK0jn-BPdVFT4YsVF21782BJGZyygeOVzc2e4fXpfrz7Fl75MjGCf1h2Q__"
"8fbc1b59-d0ec-45b6-8206-faf3b511cce4","PTRC_4patient_Plex_02_G_f11.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","800087152","0d32a54778c071651a8753972d893c4a","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f11.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=B6KClOuUGEeEndaaLbR-5bhf10m1ETZaoYusXtZlEBMlUtniaPClS0svGtaNgedSiBga-hVa4sDDdP~6GW32L3R2pPHzu23s3bIGjNL9HikWq7v2b9GZza4vnKmdKJSZ~fCRNyZqjlwaUKpjMDRaiy6gL5CTnxEQFpYDvdKTQB3KVTx1RARxtLw8mGRjewRrtf4h4572E3Zid6Rl6TWtlnTgbg7AEr76cQpXgSgzR8Sab47~N1LIHfz9gb6d0l1imiHvGgB1iedvWP17U62R17c8JTLgmAz~6TwuQqMvHI~OGDU8sRQR~IOk54BCkaT5IZd5XIgEIkDq6sEw18tOhQ__"
"98010ffb-d00a-4693-8f67-7d189b7fa7be","PTRC_4patient_Plex_01_G_f02.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","820223960","cdf061dd298ff695438a4d15de08666b","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f02.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=MoXM2lq86ib5~WRBGdYd48HVkR453Uty9BbWb3bq5w~zUnCNrPDKmGDBBLzfWAY98VHGLS-cYdnYjbJc4zNnhzRZjOgJFSinO10cGEIR8P3ZPazG6mSLgCpJ5XTKmqK9MSX8QM61iQ87WAeIKzj0DFMyqVfE1vQSq8JpdFgZruSzCGxkLPBq-AI21PAnP1PzqZG91qKzIqj4IkpYeamHYlj~K01oDVmt6TfvF2cLlfFty1w-r6M6s1i4yVGLZeAPbZq3IboXKZxUzTqxHWNszvYI3dDcZXPFm18Lcy8Qi0cJHy2gPSmP9bob56TX3l-F6cFcCkwHG1TDGpoizHkZmA__"
"a7ce97a7-202e-4e57-8c44-515e65708e14","PTRC_4patient_Plex_02_G_f07.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","860189688","015c9370dd9cf2ea7fb6f518d1cb68d8","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f07.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=XfaBN0cZlIJ2z073SpJfxl9U3IvkMr1Zd75NXKstmilZ8peNzoACuQOHWFDGYYrOeEI-giro~FM30nZsqDIH5DfGvcgIBD3IonZbCOmxdq4QKsAZ2uCZXaBaNTOyFH~2Fd75P71u4EKeuyNMl625aOyW0oeGMMb75BEu89GCej6p-5dp79E~uPEc11V4YvxOrAWJtZu5wv30KaQ5oTtodMmtd5BfdkWl645qUwdtjYZAVqRDSQkENfs~L8bkAyIFZS~byyvxpp1de8FsCynYvwkNIRUtIqZzX33hJHxHvZU9SCziTCRJjk9tlJlRSt~hMLEqSAH46fx4jl7UIAhmfA__"
"a9fb26cf-e331-4b9c-8ccc-fcadf11fe5e8","PTRC_4patient_Plex_02_G_f03.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","836872636","1ef4acaeb75882dedd68fabdb9a61b13","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f03.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=ZdXTJxfZLCbHl5mefUIB6w8LZyhBMzPzYSfT2j~6JDfk~caTHrBOrCjBKKGTsYVblujXg7uco~Gnf8weigxKP-ZVjDzP3icmBikrgXtyd2upHBZfiBmSbC~Lp-19INgqA1jSDiDHd7TZFdKG0l-7p~i-Oq9OOWdfn0xvnTMqGNVCOpzItxkJPjrlm5SnUumTOL9h3gnW8cum5lhnHgy1IYaN617sOedHZcAkqKb3zlRyzDH4sfLrVR1ehJ5yWWt6f3IUMLjmkvjgsCinNeZTjDRYuUT~jYfrY2a9vezOYWCrKhcO5e4-WzPvYzj25o7YqIuCWEBBH8oQ4UZGxz9Faw__"
"ae1ea97f-30a0-45d3-ae15-45e3ad183641","PTRC_4patient_Plex_01_G_f05.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","808517214","68a09e53f610cb6adee2fee88fdebcac","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f05.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=CyfaYF~R8rCBoMcG11L9tV9UxicAAGTsuoSea9FyJgDu-lgsusTiLW6ZhhYcAK47mpGbH7LWKxjEsCF2DEnfPpa-ddrmcUR4O1VYeAQj3EM2-ddsfqub9fPvzxWnXpaO1lAqOVkuhKc8kuYpcEQ7yuRFoKUNdrYo9ppgmZ3Zem8O4FhwZxKIeHzlJoVge8vXqvLF6fezK66ihQ4RGNWQRnlpYJPW86J~80GwOx8Mj4fdsyZoarMpCtyU3lH1mRHXmHjTvoMiJw~xL7i5jHqsOVNBKoewc~Ek2AN2JkDxqiGez83EGyFkyn9kBdgoS6FRXv50OWteJeLpdffN~Rpd0A__"
"b2c29dae-c946-438b-9eb1-67c56f428db9","PTRC_4patient_Plex_02_G_f08.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","818458264","8bfd6eddcba145b5181caef52a4ca99a","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f08.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=RVoYNBaDMbXp5ZXjVA3Qd8XEU9E05jBrUXidkcHV4e97-B-gDNcIdLLmFPVEqqYLRu~AnnJQm-rgmguiQWFXsH1s8n08uVBeo4nl35C2HjKgT2c1FBhmcxvHbP2crCqFWpeuWrvOyOChA8hzaBoyaWhXT5CzrDYkMCZDavhW88fz0hq6u5Rxzm4vhktIa7tQaykcRQ91O0SMImwDkTpdwKrShH8dy0ZCqzhvwxpE8Ctt3muy-7zLr2nYFSmP~Hj1ZU4ar6T0BlWHQZF-iezLumt79FU0ux4uZG5LnlhzvAYHb2JP9L5Eu6pfJbmnJQmseGVPP7ybSfZhPLkCsofShA__"
"b5fe13c5-a854-4bd2-aa6d-21eb9e20756f","PTRC_4patient_Plex_02_G_f12.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","818795972","c9c740f03811e32c24c8d3a13f604ae9","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f12.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=d8TkdKYiWKK9Bxm9PFQnBIsg-QGiqSGRS10f1b8RNjtm57uy2rLUW8KZ59A2FVUYfWNVEoTvyrXkJxfez5Sy166PqH1hDy8TdFw0gW2Y1hPE1A4rPJpvSbxx61uvLmf1Mpkd9E2T-Z14lnPSj1NEaRisIxFW0LLvrQ1eh4rPyYLDf7nEixzzcdApcG6cRSOmupeAkzvgRDZ3jreiWJ23xuHtbmkTcK2~fQ9A02OhDkT2ZKhbHfGXdHH5UaDAID47DLkl9C6FAv6PSAOYdlFblkON2vpM5V4~ivqOWhkQNUexjgfyU8LPXr84E9QC0W16G-3IL5SJAh1pblD1o-mL0Q__"
"cefa4e3b-85dd-488c-a465-a370720aa182","PTRC_4patient_Plex_01_G_f03.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","833503472","9ecac05a39dd71a0a4290be56b1d3afd","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f03.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=XD-Qj-wc39LYTac-UDDXnuSvUpAwmufHxb1VhW-jby1UKNY6xxLafbwLgixiLi3C9xaxO8LLtyyzG9dqq61vXG-3~Vaq~RqSDOiY-sstrKBkKL8KF06mvVf~M3hmh8QIPAkvwH8MTFNgFIqtuAqnjEf0kFiwdJ8vSvXc7K~2YPqnm6XbzlPpv-CfGgsxXwBYLxtIAuRfVAbzJamfMDZxzzqqzWGD~Z0-C9Og7BhwFn3GfJ9DFlh7Rfno9mQaFx-fcGLgC3Od9AEkJNEKIwfxunj8y-bbDdOPJih~3BjNHjAuRhveNz0rzm~hYqs5nhz7NY4mAamGRiNbjvNcnaastg__"
"d0a63d47-4d79-457b-a20f-d0c555914e15","PTRC_4patient_Plex_02_G_f10.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","808441952","a17aba24024b82c4653056cbd1c55e39","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f10.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=RhYzgg2NpUXvncXIHCp~1sXzbl4mNOiFT-pj54MV-lWQoHng~GWsAVt7arBPRqKu3squMcfDZbIdVRzvPM0UxUrdyn3ABB9hoFtPzJ972psP5fg0KMCpFmxAkkd72of0E8NGsQPDlXNcElStzEM-Go92yNleec~KunYQOIBiCh3Usbfvr~pKdlaqk1RYD6UsMQwhTe60Oa~ii-2EM5kAwUoipnOwdCaGUIbY43l1IGAXM9PzlgDK7IuY1Z5Bohg7S4CHWbLH0FGcWPt8EJXmVGuBa6UO9gs7ZnXQLegUakV6bdQ624aSBgQ1LigNsq~eT6aw9fV5OmLBGt~C4BSgAQ__"
"e26b25e4-9866-474b-b85c-c3f27191ee8f","PTRC_4patient_Plex_01_G_f10.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","852473788","9f04302de9e7fa65f279478d7184043e","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f10.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=B35BBQVFMvbo7xVE4DszXBR11u5EBYLXoU-OZdFBwPNePPz2wxaNxPSOPSdQ7u4UQAzVjG4IGx0rLvPS0Uh21~F7Uw3o6Sk4MdMwEY9eR3oZB~ECN0kCouXRcFInnjzZk~JpQSEUo6Wrp8ggQU9IjmZsP9TLUp~q2Bfc1rS4QoUBsnqkch8JQol2jwfnZjY9YquW9wSDtAD8uXKR6Z1QzZ7WObR8KMXhjEsJbl23g42-oC8chS7uBWx-7yWuvEAHldFz49Sej3P76MeRCSBZByWaF0I2~V89bp4zBg4a9LLcy7mJsOTerp4KSIkgn1x-WrCM5HlnmFhRiYJ5xKtHSg__"
"e5834369-f8ed-4ca5-8ded-34cad2070816","PTRC_4patient_Plex_01_G_f07.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-2","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","781092452","9869492201c5c54aee97d3e76919d97a","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_01_G_f07.raw?Expires=1685428604&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=EkkM5W7ni9UxiWkCGPNBux0XUUeMFegRB2LVAISzQJUpZGdG-jdDjIXO7B7VqEsCyD6mL98B82naC~3Wpmo8-3EmZe8nCLNYo0lEJhyxPjTdEskVOgZhFfwnXMCQDeOIVWq7o2GoxghDgrKoHy4Fw1C-4WBmMwVa4SMEymYc042jnnSYggaXElJ5V~Ls7gbMC3zQkYFJMivoYSAFrSPqmugeEsF4DHlYvsfyEvyD9Hh8qLHiL2YLVFUI2STddhgIuDOCo9uym08mIQH4vpk79njtVO4Cgc91P~Zs~4qAQGnG4rzgjT3-fec7ZFMw34BYjQZr4EeC4DgiMCcbn4H6cA__"
"eb050e79-0973-4aac-8025-42bc7e0f5b75","PTRC_4patient_Plex_02_G_f01.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","882570908","87c2dbc2113b544feaf5dd00c476beca","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f01.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=HbW7zXuD8gNT5F9SK3PKxJksEVptcWG15APT8tU7EBUaRWrpUMTKxPGL70Fj3bqlKsR0tB117gInY98ChQgQBRud4CA2zo-XwrvXI65yAVVMY16~iuleOZwd1IWrcnDAQztqh2fTgOJm-D57FP4z-yo-sYARAbEhJgPbe0mBWx1eNyqbS3Py8kpPPjm2GXGfKarj5bWdqqmFz0X3fUW3wBUQIFOhuT0cx6LwIriGTUo0gPuVbZkgNOuL84nWPx4U8gfJKnL-LoErshM46JaINrL8YAbUNcgl2SIgn7HH6CRKMNyNOcpmJ1ZWXEDBaKQqdF0arriB7GxfiJHIn0cG~g__"
"ff6d6d5c-acf9-4cb1-b45f-cd07c970c7f4","PTRC_4patient_Plex_02_G_f09.raw","AML Ex Vivo Drug Response: Sorafenib Treatment - Proteome-1","AML Ex Vivo Drug Response - Sorafenib Treatment - Proteome","PDC000400","1","7746b4e0-6b8a-4d3d-a0bd-0d06059ac001","Proteogenomic Translational Research Centers (PTRC)","Raw Mass Spectra","Proprietary","Open","824336384","ec515d1992c05c02b5a145e134e222de","Yes","https://d3iwtkuvwz4jtf.cloudfront.net/raw-files/124/161/PTRC_4patient_Plex_02_G_f09.raw?Expires=1685428605&Key-Pair-Id=APKAIXDMVIARW22I7ILQ&Signature=BsnmXvcJFIC6GcOTCv1avIyoC0Cnuilx5VTHmVoqBxi6oOz7O1akrNTSFEUre1YnvRPmZIbtR9q9YgqIlGRjalbSH17IkYV6l2k7XSotkTz8~8PGtoL49lRT6WhS60d6gc0DRaZiuu03Ciw0yu7KzSEbqMZsXrJQBg4PyRDpLLcOODwLw2OALiGxsYOu~dQ1BFRc66EPzRpbQxYt8pPSjJDSazJAeupA8TZYFq0pr7vXgV6AC6lLk589he8UAEBjucdvdD5fYPNF3iwLd1MgRFnHC6ZhliLdV5p~djuiwc2UqtiDuziI-XRciHSbQEwta~XYr78-GJ43lIF8d09SMw__"
